PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Pulmonary Aspergillosis D055732 1 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Decapitation D049248 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Respiratory Sounds D012135 3 associated lipids
HTLV-I Infections D015490 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Ascariasis D001196 3 associated lipids
Cholangitis D002761 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Nasal Obstruction D015508 4 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Thrombophilia D019851 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Sneezing D012912 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Folliculitis D005499 7 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Leiomyoma D007889 8 associated lipids
Thyroid Diseases D013959 8 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Rhinitis D012220 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Restenosis D023903 10 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Liver Failure, Acute D017114 11 associated lipids
Dehydration D003681 11 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Urticaria D014581 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sarcoidosis D012507 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Encephalitis D004660 15 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Astrocytoma D001254 15 associated lipids
Blister D001768 16 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Down Syndrome D004314 18 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Bronchial Spasm D001986 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hypothermia D007035 19 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Peptic Ulcer D010437 19 associated lipids
Cough D003371 19 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Fox CC et al. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. 1990 Gastroenterology pmid:1693122
Ikai K and Fukushima M Effects of cytotoxic prostaglandin, delta 12-PGJ2 on protein synthesis and cytoskeleton in transformed epidermal cells in culture. 1990 Arch. Dermatol. Res. pmid:1693839
Ashby B Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. 1990 Mol. Pharmacol. pmid:1695318
Atkins PC et al. In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration. 1990 J. Allergy Clin. Immunol. pmid:1698845
Pipkorn U H1-antagonists as a tool in clarifying the pathophysiology of nasal allergy. 1990 Clin. Exp. Allergy pmid:1699643
Knapp HR Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. 1990 N. Engl. J. Med. pmid:1701029
Liu MC et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. 1990 Am. Rev. Respir. Dis. pmid:2368958
García-Sáinz JA et al. Melittin stimulates liver glycogenolysis and the release of prostaglandin D2 and thromboxane B2. 1990 Biochem. J. pmid:2375756
Zavoico GB et al. Enhancement of thrombin- and ionomycin-stimulated prostacyclin and platelet-activating factor production in cultured endothelial cells by a tumor-promoting phorbol ester. 1990 J. Cell. Physiol. pmid:2113537
Woodward DF et al. Studies on the ocular pharmacology of prostaglandin D2. 1990 Invest. Ophthalmol. Vis. Sci. pmid:2298534
Goh Y and Nakajima M Stimulatory effects of prostaglandin D2 analogues on adenylate cyclase in rabbit iris-ciliary body membrane fractions. 1990 Exp. Eye Res. pmid:2249731
Khan SH and Sorof S Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. 1990 Proc. Natl. Acad. Sci. U.S.A. pmid:2251282
Nishimura G [Antitumor activity and cell cycle effects of delta 12-PGJ2 in vivo]. 1990 Nihon Gan Chiryo Gakkai Shi pmid:2351856
Ford WD et al. Pulmonary hypertension in lambs with congenital diaphragmatic hernia: vasodilator prostaglandins, isoprenaline, and tolazoline. 1990 J. Pediatr. Surg. pmid:2352080
Okumura T and Saito K Effect of prostaglandins on glycogenesis and glycogenolysis in primary cultures of rat hepatocytes--a role of prostaglandin D2 in the liver. 1990 Prostaglandins pmid:2353117
Williams WR et al. In vitro tests for the diagnosis of aspirin-sensitive asthma. 1990 J. Allergy Clin. Immunol. pmid:2146311
Winter JS et al. A stimulatory effect of interleukin-1 on adrenocortical cortisol secretion mediated by prostaglandins. 1990 Endocrinology pmid:2169407
Atsmon J et al. Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. 1990 Cancer Res. pmid:2306739
Kikuchi Y et al. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma]. 1990 Nippon Sanka Fujinka Gakkai Zasshi pmid:2313142
Nambu F et al. Inhibitory effects of OKY-046 on spasmogen-induced bronchoconstrictions in sensitized and non-sensitized guinea pigs. 1990 Jpn. J. Pharmacol. pmid:2313938
Simpkins CO et al. Prostaglandin D2 modulates human neutrophil intracellular calcium flux and inhibits superoxide release via its ring carbonyl. 1990 Life Sci. pmid:2319907
Gadsby JE et al. Prostaglandin F2 alpha receptors on enzyme-dissociated pig luteal cells throughout the estrous cycle. 1990 Endocrinology pmid:2153525
Friedmann PS et al. Ultraviolet stimulated melanogenesis by human melanocytes is augmented by di-acyl glycerol but not TPA. 1990 J. Cell. Physiol. pmid:2303529
Urade Y et al. Mast cells contain spleen-type prostaglandin D synthetase. 1990 J. Biol. Chem. pmid:2403560
Mori H et al. Augmentation of antiproliferative activity of recombinant human tumor necrosis factor by delta 12-prostaglandin J2. 1990 J Biol Response Mod pmid:2341865
Bochner BS et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. 1990 J. Allergy Clin. Immunol. pmid:2262641
Doyle WJ et al. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. 1990 J. Allergy Clin. Immunol. pmid:2262647
Kudo M et al. [Prostaglandin D2-endogenous regulator of physiological sleep-inhibited CRF-induced ACTH secretion from rat anterior pituitary cells]. 1990 Nihon Naibunpi Gakkai Zasshi pmid:1962750
Nishino S et al. Prostaglandin E2 levels in cerebrospinal fluid of normal and narcoleptic dogs. 1990 Biol. Psychiatry pmid:2268692
Kawano S et al. Protective effect of PGD2 against ethanol-induced gastric mucosal injury in rats. 1990 J. Clin. Gastroenterol. pmid:2212542
Woodward DF et al. Thromboxane A2-mimetics are potent microvascular permeability factors in the conjunctiva. 1990 J. Pharmacol. Exp. Ther. pmid:2213558
Katsuura G et al. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. 1990 Am. J. Physiol. pmid:1967907
Vigano' T et al. Binding sites for histamine and sulfidopeptide leukotrienes in normal and hypersensitized human lung fragments. 1990 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2144691
Eggleston PA et al. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells. 1990 Am. Rev. Respir. Dis. pmid:1691604
Fukushima M Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved. 1990 Eicosanoids pmid:2073399
Inoue M et al. Interactions between the brain renin-angiotensin system and brain prostanoids in the control of vasopressin secretion. 1990 Exp Brain Res pmid:2073934
Bennegård B et al. Luteotropic effects of prostaglandins I2 and D2 on isolated human corpora luteum. 1990 Fertil. Steril. pmid:2168845
Eriksson LO et al. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography. 1990 Acta Physiol. Scand. pmid:2173350
Brass EP and Garrity MJ Structural specificity for prostaglandin effects on hepatocyte glycogenolysis. 1990 Biochem. J. pmid:2158311
Lysz TW et al. Kupffer cell-hepatocyte interactions and the changes in 1-14C-arachidonate incorporation in response to endotoxin in vitro. 1990 Prostaglandins pmid:2112770
Jongejan RC et al. Effects of inflammatory mediators on the responsiveness of isolated human airways to methacholine. 1990 Am. Rev. Respir. Dis. pmid:2240835
Marui N et al. N-myc suppression and cell cycle arrest at G1 phase by prostaglandins. 1990 FEBS Lett. pmid:2226777
Koyama Y et al. Prostaglandin production by isolated Kupffer cells. 1990 Gastroenterol. Jpn. pmid:2227259
Okuda-Ashitaka E et al. Cyclic AMP-mediated inhibition of cell growth by prostaglandin D2 in a fibroblastic cell line (EBTr). 1990 Eicosanoids pmid:1705811
Hamid-Bloomfield S et al. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C. 1990 Br. J. Pharmacol. pmid:2119842
Ito S et al. Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP-receptors on human platelets, with a PGD2-responsive cell line from bovine embryonic trachea. 1990 Br. J. Pharmacol. pmid:2158830
Tzung SP et al. Suppression of hepatic lymphokine-activated killer cell induction by murine Kupffer cells and hepatocytes. 1990 Hepatology pmid:2210667
White RP et al. Eicosanoid levels in CSF of premature infants with posthemorrhagic hydrocephalus. 1990 Am. J. Med. Sci. pmid:2321665
Uda R et al. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. 1990 Brain Res. pmid:2322844
Miadonna A et al. Mediator release after endobronchial antigen challenge in patients with respiratory allergy. 1990 J. Allergy Clin. Immunol. pmid:1692050
Schulman ES et al. Histochemical heterogeneity of dispersed human lung mast cells. 1990 J. Immunol. pmid:1692857
Saitoh O et al. Effect of amogastrin on the release of various prostaglandins into gastric lumen in man. 1989 Mar-Apr Jpn. J. Med. pmid:2733241
Tejedor M et al. Potentiation of radiation toxicity in C-6 glioma cells by prostaglandin D2. 1989 Jul-Aug Anticancer Res. pmid:2817802
Black PN et al. Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. 1989 Thorax pmid:2548300
Rossi AG and O'Flaherty JT Prostaglandin binding sites in human polymorphonuclear neutrophils. 1989 Prostaglandins pmid:2549574
Kuiper J et al. Induction of ornithine decarboxylase in rat liver by phorbol ester is mediated by prostanoids from Kupffer cells. 1989 J. Biol. Chem. pmid:2708347
Ishikawa H et al. [Changes of protein and RNA content in accumulated G1 cells by delta12-PGJ2]. 1989 Gan To Kagaku Ryoho pmid:2930205
Kerr JS et al. Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. 1989 Biochem. Biophys. Res. Commun. pmid:2558648
Koshihara Y and Kawamura M Prostaglandin D2 stimulates calcification of human osteoblastic cells. 1989 Biochem. Biophys. Res. Commun. pmid:2930558
Naclerio RM et al. The effect of cetirizine on early allergic response. 1989 Laryngoscope pmid:2566879
Ohuchi K et al. Stimulation of histamine release and arachidonic acid metabolism in rat peritoneal mast cells by thapsigargin, a non-TPA-type tumor promoter. 1989 Biochim. Biophys. Acta pmid:2469475
Wolfe LS et al. Synthesis and functions of cyclooxygenase and lipoxygenase products in brain: new findings and an appraisal. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2568735
Wolfe LS and Pellerin L Arachidonic acid metabolites in the rat and human brain. New findings on the metabolism of prostaglandin D2 and lipoxygenase products. 1989 Ann. N. Y. Acad. Sci. pmid:2570544
Bhattacharya SK et al. Effect of centrally administered prostaglandin D2 and some prostaglandin synthesis inhibitors on carrageenan-induced paw oedema in rats. 1989 J. Pharm. Pharmacol. pmid:2571705
Zehr BB et al. Use of segmental airway lavage to obtain relevant mediators from the lungs of asthmatic and control subjects. 1989 Chest pmid:2539958
Benyon RC The human skin mast cell. 1989 Clin. Exp. Allergy pmid:2667702
Leynadier F [Mast cells and basophils in asthma]. 1989 Ann. Biol. Clin. (Paris) pmid:2675683
Hamid-Bloomfield S and Whittle BJ Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. 1989 Br. J. Pharmacol. pmid:2647205
Kuiper J et al. The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver. 1989 Agents Actions pmid:2653002
Ikai K et al. Inhibitory effect of tranilast on prostaglandin D synthetase. 1989 Biochem. Pharmacol. pmid:2475113
Woodward DF et al. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure. 1989 Ophthalmic Res. pmid:2626239
Nishino S et al. Salivary prostaglandin concentrations: possible state indicators for major depression. 1989 Am J Psychiatry pmid:2627202
Salari H and Chan-Yeung M Interleukin-1 potentiates antigen-mediated arachidonic acid metabolite formation in mast cells. 1989 Clin. Exp. Allergy pmid:2513105
Chakraborti S et al. Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium. 1989 Am. J. Physiol. pmid:2514605
Trist DG et al. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. 1989 Br. J. Pharmacol. pmid:2466517
Yoshimura S et al. Prostaglandin D2 receptor of mastocytoma P-815 cells--possible regulation by phosphorylation and dephosphorylation. 1989 Biochim. Biophys. Acta pmid:2497784
Ikai K et al. Prostaglandin D2, a mediator in both immediate and delayed-type immune reactions in the skin. 1989 Dermatologica pmid:2506083
Hatanaka M et al. Late-phase accumulation of inositol phosphates stimulated by prostaglandins D2 and F2 alpha in neuroblastoma x glioma hybrid NG108-15 cells. 1989 J. Neurochem. pmid:2507741
Urade Y et al. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. 1989 J. Immunol. pmid:2509561
Ito S et al. Prostaglandin D2: a biochemical perspective. 1989 Prostaglandins Leukot. Essent. Fatty Acids pmid:2510183
Lapointe DS and Olson MS Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid. 1989 J. Biol. Chem. pmid:2501299
Virgolini I et al. Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trial. 1989 Prostaglandins Leukot. Essent. Fatty Acids pmid:2514430
Robinson C et al. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells. 1989 J. Invest. Dermatol. pmid:2504819
Asbóth G et al. The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation. 1989 Biochim. Biophys. Acta pmid:2493805
Stürzebecher S et al. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets. 1989 Prog. Clin. Biol. Res. pmid:2477855
Cohan VL et al. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. 1989 Am. Rev. Respir. Dis. pmid:2478059
Reshef A et al. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). 1989 J. Allergy Clin. Immunol. pmid:2478604
Marone G et al. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion. 1989 Life Sci. pmid:2480501
Giles H et al. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. 1989 Br. J. Pharmacol. pmid:2924081
Reiss TF et al. Local mediator release after antigen challenge of a bronchial segment in allergic dogs. 1989 Am. J. Physiol. pmid:2481982
Sugama K et al. Stimulation of cAMP formation by prostaglandin D2 in primary cultures of bovine adrenal medullary cells: identification of the responsive population as fibroblasts. 1989 Biochim. Biophys. Acta pmid:2538150
Morrow JD et al. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. 1989 Prostaglandins pmid:2475889
Gray PR et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. 1989 Am. Rev. Respir. Dis. pmid:2502051
Froissart P et al. Modulation by phorbol 12-myristate 13-acetate of arachidonic acid release from rat basophilic leukemia cells stimulated with A23187. 1989 Biochim. Biophys. Acta pmid:2496761
Watanabe K [Structure and function of prostaglandin F synthetase]. 1989 Seikagaku pmid:2693551
Keenan CM and Rangachari PK Eicosanoid interactions in the canine proximal colon. 1989 Am. J. Physiol. pmid:2539737
Hayaishi O Prostaglandin D2 and sleep. 1989 Ann. N. Y. Acad. Sci. pmid:2774407
Deckers IA et al. Evidence for the involvement of prostaglandins in modulation of acetylcholine release from canine bronchial tissue. 1989 Eur. J. Pharmacol. pmid:2806380
Kuiper J et al. Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells. 1989 Biochem. J. pmid:2818563
Rodriguez y Baena R et al. Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. 1989 J. Neurosurg. pmid:2585083